[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-EP1980251,2008,A1
62089-16-1
62089-04-7
1065267-25-5 | 1-(3,5-Difluoropyridin-2-yl)ethanamine hydrochloride | AA0083GS | MFCD17392840
1072945-68-6 | 4-(Cyclopropanesulfonamido)phenylboronic acid | AA0090C6 | MFCD10699614
137160-11-3 | CNS-1102 | AA009GUS | MFCD00867728
167105-80-8 | Ketorolac Related Compound A (20 mg) (5-benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrrolizine-1-carboxamide) | AA00ADZQ | MFCD27978189
25487-28-9 | TalsupraM hydrochloride | AA00BJOX | MFCD01663632
37804-11-8 | 3-AMINO-6-CHLORO-5-DIMETHYLAMINO-N-2-PYRIDINYLPYRAZINECARBOXAMIDE HYDROCHLORIDE | AA00CHK3 | MFCD08703105
5060-65-1 | 2,6-NAPHTHALENEDICARBALDEHYDE | AA00DGCL | MFCD00462585
631862-75-4 | N-[2-(2-Amino-4-chlorophenoxy)ethyl]-n,n-dimethylamine | AA00EJ63 | MFCD08686778
835-71-2 | 2-(P-Tolyl)benzoxazole | AA00G9YS | MFCD00042917
1191063-34-9 | 2-Amino-5-chloro-4-fluorophenol | AA00HEUV | MFCD19374214